AssetMark Inc’s Phio Pharmaceuticals PHIO Stock Holding History

AssetMark Inc’s Portfolio PHIO Stock Details PHIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$113	Hold	110	–	–	﹤0.01%	3682
2026 Q2	$113	Hold	110	–	–	﹤0.01%	3468
2026 Q1	$134	Hold	110	–	–	﹤0.01%	3362
2025 Q4	$116	Hold	110	–	–	﹤0.01%	3297
2025 Q3	$273	Hold	110	–	–	﹤0.01%	3016
2025 Q2	$259	Hold	110	–	–	﹤0.01%	2843
2025 Q1	$143	Buy	+110	New	+$203	﹤0.01%	2548

Other funds holding PHIO

Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

AssetMark Inc's PHIO Position: Q3 2026 in Review

AssetMark Inc held its Phio Pharmaceuticals (PHIO) position steady in Q3 2026 at 110 shares worth $113. The position accounts for ﹤0.01% of the portfolio, ranked #3682.

AssetMark Inc first reported a position in PHIO in Q1 2025 and has held it in 7 quarters since. The position peaked at $273 in Q3 2025. 2 funds tracked by Wall St. Rank hold PHIO as of Q3 2026.

AssetMark Inc held 110 shares of Phio Pharmaceuticals worth $113 as of Q3 2026.
AssetMark Inc left its Phio Pharmaceuticals share count unchanged in Q3 2026.
Phio Pharmaceuticals made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #3682 holding.
AssetMark Inc first reported a position in Phio Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
AssetMark Inc's Phio Pharmaceuticals position peaked at $273 in Q3 2025.
2 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.